112 Participants Needed

Neurofeedback for Mild Cognitive Impairment

VG
FS
BC
JP
Overseen ByJoshua Phillips, B.S.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of California, San Diego
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

Mild cognitive impairment (MCI) has been identified as an early phase of Alzheimer's disease (AD), a neurodegenerative disorder expected to affect 13.9 million Americans by 2060. AD causes a progressive cognitive decline, including problems related to learning and memory, that adversely affects life quality. Treatment intervention at the MCI stage of the disease could potentially slow down the rate at which people may convert from MCI to AD. Increasing evidence suggests that abnormal activity in frontal regions of the brain is associated with cognitive deficits observed in AD. Furthermore, previous research has shown that neurofeedback (NFB) training targeting these regions can improve memory, making it a potential treatment for AD. NFB is a technique where an individual learns to change his/her brain function in a particular direction, once that function has been made accessible through a visual or auditory metaphor. We are proposing a novel, computer-based brain-training program to enhance frontal gamma oscillatory activity in individuals with MCI. Results from this study will build the scientific foundation necessary for larger clinical trials dedicated to improving treatment options and outcomes for patients with MCI.

Will I have to stop taking my current medications?

The trial requires that you stop taking medications likely to affect cognitive function, such as donepezil and memantine. Other medications are not excluded, but their effects will be examined during the study.

What data supports the effectiveness of the treatment Neurofeedback for Mild Cognitive Impairment?

Research shows that neurofeedback, a type of biofeedback that uses real-time brain activity to improve brain function, has been effective in enhancing cognitive functions like memory and attention in both healthy and older adults. Studies have demonstrated improvements in working memory and attention, suggesting potential benefits for those with mild cognitive impairment.12345

Is neurofeedback safe for humans?

Neurofeedback, including methods like EEG and fMRI neurofeedback, has been studied in humans for various conditions, and no significant safety concerns have been reported in these studies. It is generally considered a non-invasive and safe method for modulating brain activity.678910

How does the treatment Neurofeedback differ from other treatments for Mild Cognitive Impairment?

Neurofeedback is unique because it uses real-time brain activity monitoring to train the brain, aiming to improve memory and attention in people with Mild Cognitive Impairment. Unlike traditional treatments, it is non-invasive and involves training sessions that help enhance brain function by modulating brain waves, which has shown promising results in improving cognitive abilities.12101112

Eligibility Criteria

This trial is for individuals living independently with mild cognitive impairment (MCI), who can read English and consent to participate. It's not suitable for those with frontal temporal dementia, brain cancer, or recent stroke; people taking certain cognitive-affecting drugs like donepezil; or those with a history of significant head injury, seizures, or active substance abuse within the last year.

Inclusion Criteria

I understand and agree to participate in this study voluntarily.
I live on my own without needing daily help.
Literate in English.
See 1 more

Exclusion Criteria

You have had problems with drugs or alcohol within the past year.
The potential benefits of the study do not outweigh the potential risks of the study, as determined by the PI.
I am taking medication for epilepsy.
See 6 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive gamma-neurofeedback (G-NFB) or placebo-NFB during 30-45 minute sessions twice per week for 12 weeks

12 weeks
24 visits (in-person)

Follow-up

Participants are monitored for durability of gamma band response and working memory accuracy after treatment

4 weeks
1 visit (in-person)

Treatment Details

Interventions

  • Neurofeedback
Trial OverviewThe study tests a computer-based neurofeedback program designed to improve working memory in MCI patients by enhancing brain activity. Participants will either receive this neurofeedback training or a placebo treatment to compare effectiveness in potentially slowing Alzheimer's progression.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active TreatmentExperimental Treatment1 Intervention
Subjects will be given a choice of videos consisting of still images set to music. Whether the video progresses and music continues to play will depend on the subject's ability to maintain frontal gamma oscillatory activity within a prespecified range. Over successive weeks, the parameters for positive feedback (music and video progression) will become incrementally more difficult.
Group II: PlaceboPlacebo Group1 Intervention
Video and music progression will be random and will not depend on brain activity. Any progression will be by random chance alone.

Neurofeedback is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as Neurofeedback for:
  • Chronic low back pain
  • Fibromyalgia
  • Neuropathic pain
🇪🇺
Approved in European Union as Neurofeedback for:
  • Chronic pain
  • Fibromyalgia
  • Neuropathic pain
🇨🇦
Approved in Canada as Neurofeedback for:
  • Chronic pain
  • Fibromyalgia

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, San Diego

Lead Sponsor

Trials
1,215
Recruited
1,593,000+

Findings from Research

Neurofeedback, which provides real-time sensory rewards based on brain activity, shows promise in improving memory and cognition in both healthy young and older adults, although training typically requires multiple weeks with several sessions per week.
Despite the overall positive trend in memory improvement, individual responses to neurofeedback can vary significantly, with some individuals not benefiting from the training, highlighting the need for further research into psychological factors and personalized approaches.
Sharpening Working Memory With Real-Time Electrophysiological Brain Signals: Which Neurofeedback Paradigms Work?Jiang, Y., Jessee, W., Hoyng, S., et al.[2023]
Neurofeedback (NF) has been shown to enhance cognitive functions like attention and working memory, particularly in children with ADHD, and there is growing evidence that it can also benefit older adults by helping their brain function more like that of younger individuals.
Recent advancements in technology, such as wireless brain activity recording and machine learning, are paving the way for more effective NF training, offering hope for improving cognitive performance and combating age-related cognitive decline in older populations.
Tuning Up the Old Brain with New Tricks: Attention Training via Neurofeedback.Jiang, Y., Abiri, R., Zhao, X.[2020]
In a study involving 26 participants (16 healthy elderly and 10 with prodromal Alzheimer's disease), real-time fMRI neurofeedback training improved visuospatial memory performance, suggesting it may help counteract cognitive decline associated with aging and early Alzheimer's.
The training led to changes in cerebral connectivity, particularly involving the parahippocampus and precuneus, and increased grey matter volumes in the precuneus and frontal cortex, indicating potential structural brain changes linked to the neurofeedback intervention.
Cognitive Improvement and Brain Changes after Real-Time Functional MRI Neurofeedback Training in Healthy Elderly and Prodromal Alzheimer's Disease.Hohenfeld, C., Nellessen, N., Dogan, I., et al.[2022]

References

Sharpening Working Memory With Real-Time Electrophysiological Brain Signals: Which Neurofeedback Paradigms Work? [2023]
Tuning Up the Old Brain with New Tricks: Attention Training via Neurofeedback. [2020]
Cognitive Improvement and Brain Changes after Real-Time Functional MRI Neurofeedback Training in Healthy Elderly and Prodromal Alzheimer's Disease. [2022]
EEG biofeedback of low beta band components: frequency-specific effects on variables of attention and event-related brain potentials. [2022]
EEG-neurofeedback for optimising performance. I: a review of cognitive and affective outcome in healthy participants. [2022]
Neural and functional validation of fMRI-informed EEG model of right inferior frontal gyrus activity. [2023]
SMR/Theta Neurofeedback Training Improves Cognitive Performance and EEG Activity in Elderly With Mild Cognitive Impairment: A Pilot Study. [2020]
A multicenter effectiveness trial of QEEG-informed neurofeedback in ADHD: Replication and treatment prediction. [2022]
Functional magnetic resonance imaging (FMRI) neurofeedback: implementations and applications. [2022]
Neurofeedback Improves Memory and Peak Alpha Frequency in Individuals with Mild Cognitive Impairment. [2022]
Adaptive P300-Based Brain-Computer Interface for Attention Training: Protocol for a Randomized Controlled Trial. [2023]
Comparison of effects between SMR/delta-ratio and beta1/theta-ratio neurofeedback training for older adults with Mild Cognitive Impairment: a protocol for a randomized controlled trial. [2020]